UBS Group’s Radius Health, Inc. RDUS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-1,402,201
| Closed | -$14.5M | – | 11753 |
|
|
2022
Q2 | $14.5M | Buy |
1,402,201
+54,252
| +4% | +$403K | 0.01% | 1553 |
|
|
2022
Q1 | $11.9M | Sell |
1,347,949
-530,252
| -28% | -$4.02M | ﹤0.01% | 1806 |
|
|
2021
Q4 | $13M | Buy |
1,878,201
+1,766,933
| +1,588% | +$25.9M | ﹤0.01% | 1921 |
|
|
2021
Q3 | $1.38M | Buy |
111,268
+66,548
| +149% | +$959K | ﹤0.01% | 3901 |
|
|
2021
Q2 | $816K | Sell |
44,720
-20,493
| -31% | -$407K | ﹤0.01% | 4357 |
|
|
2021
Q1 | $1.36M | Buy |
65,213
+60,079
| +1,170% | +$1.27M | ﹤0.01% | 3939 |
|
|
2020
Q4 | $92K | Buy |
5,134
+1,379
| +37% | +$20.7K | ﹤0.01% | 5746 |
|
|
2020
Q3 | $43K | Sell |
3,755
-2,601
| -41% | -$32.1K | ﹤0.01% | 5767 |
|
|
2020
Q2 | $87K | Buy |
6,356
+67
| +1% | +$923 | ﹤0.01% | 5414 |
|
|
2020
Q1 | $82K | Sell |
6,289
-20,260
| -76% | -$361K | ﹤0.01% | 5452 |
|
|
2019
Q4 | $535K | Sell |
26,549
-54,459
| -67% | -$1.32M | ﹤0.01% | 4787 |
|
|
2019
Q3 | $2.09M | Sell |
81,008
-46,768
| -37% | -$1.15M | ﹤0.01% | 3249 |
|
|
2019
Q2 | $3.11M | Buy |
127,776
+16,467
| +15% | +$360K | ﹤0.01% | 2744 |
|
|
2019
Q1 | $2.22M | Sell |
111,309
-142,363
| -56% | -$2.6M | ﹤0.01% | 2905 |
|
|
2018
Q4 | $4.18M | Buy |
253,672
+87,866
| +53% | +$1.48M | ﹤0.01% | 2318 |
|
|
2018
Q3 | $2.95M | Buy |
165,806
+87,655
| +112% | +$1.98M | ﹤0.01% | 2838 |
|
|
2018
Q2 | $2.3M | Sell |
78,151
-165,187
| -68% | -$5.22M | ﹤0.01% | 3041 |
|
|
2018
Q1 | $8.74M | Buy |
243,338
+31,617
| +15% | +$1.14M | ﹤0.01% | 1816 |
|
|
2017
Q4 | $6.73M | Buy |
211,721
+67,357
| +47% | +$2.11M | ﹤0.01% | 2065 |
|
|
2017
Q3 | $5.57M | Buy |
144,364
+98,968
| +218% | +$3.88M | ﹤0.01% | 2106 |
|
|
2017
Q2 | $2.05M | Buy |
45,396
+27,403
| +152% | +$1.05M | ﹤0.01% | 2985 |
|
|
2017
Q1 | $695K | Sell |
17,993
-57,423
| -76% | -$2.41M | ﹤0.01% | 3803 |
|
|
2016
Q4 | $2.87M | Buy |
75,416
+1,648
| +2% | +$78.4K | ﹤0.01% | 2588 |
|
|
2016
Q3 | $3.99M | Sell |
73,768
-40,674
| -36% | -$2.07M | ﹤0.01% | 2233 |
|
|
2016
Q2 | $4.21M | Buy |
114,442
+112,643
| +6,261% | +$3.98M | ﹤0.01% | 2095 |
|
|
2016
Q1 | $57K | Sell |
1,799
-45,623
| -96% | -$1.58M | ﹤0.01% | 5406 |
|
|
2015
Q4 | $2.92M | Sell |
47,422
-27,233
| -36% | -$1.72M | ﹤0.01% | 2459 |
|
|
2015
Q3 | $5.17M | Sell |
74,655
-1,695
| -2% | -$118K | ﹤0.01% | 1893 |
|
|
2015
Q2 | $5.17M | Sell |
76,350
-25,190
| -25% | -$1.17M | ﹤0.01% | 2035 |
|
|
2015
Q1 | $4.18M | Buy |
+101,540
| New | +$4.56M | ﹤0.01% | 2225 |
|
Other funds holding RDUS
UBS Group's RDUS Position: Q3 2022 in Review
UBS Group sold out of Radius Health, Inc. (RDUS) in Q3 2022, closing a stake of 1,402,201 shares — an estimated $14.5M sold.
UBS Group first reported a position in RDUS in Q1 2015 and held it in 30 quarters. The position peaked at $14.5M in Q2 2022. 1 fund tracked by Wall St. Rank holds RDUS as of Q3 2022.
- UBS Group reported no remaining Radius Health, Inc. position as of Q3 2022 after selling out during the quarter.
- UBS Group sold 1,402,201 Radius Health, Inc. shares in Q3 2022, an estimated $14.5M.
- UBS Group first reported a position in Radius Health, Inc. in Q1 2015 and held it in 30 quarters.
- UBS Group's Radius Health, Inc. position peaked at $14.5M in Q2 2022.
- 1 fund tracked by Wall St. Rank held Radius Health, Inc. as of Q3 2022.
Based on UBS Group's 13F filing for Q3 2022, filed 10 Nov 2022.